Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | TriSalus Life Sciences, Inc. | Wahlstrom Mats
(Director) |
P | Common Stock | A | 10727 | $4.16 - $4.44 | $47,056 |
| 2024-11-14 | TriSalus Life Sciences, Inc. | Marshak Richard
(SR.VP, CORP. DEV. & STRATEGY) |
A | Common Stock | A | 6875 | $0.00 - $0.00 | $0 |
| 2024-09-12 | TriSalus Life Sciences, Inc. | Szela Mary T
(CEO AND PRESIDENT) |
P | Common Stock | A | 14815 | $4.83 - $5.20 | $75,358 |
| 2024-09-10 | TriSalus Life Sciences, Inc. | Szela Mary T
(CEO AND PRESIDENT) |
P | Common Stock | A | 5000 | $4.97 - $4.97 | $24,850 |
| 2024-08-28 | TriSalus Life Sciences, Inc. | Martin George Kelly
(Director) |
S | Common Stock | D | 9 | $5.50 - $5.50 | $49 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |